Clinical Scenarios Favoring Monotherapy IGF-1 is 20-30% below the age-adjusted reference range but not severely deficient The patient is age 30% below range) | | Age | 50 | | Prior response to sermorelin | IGF-1 normalized at 12 weeks | IGF-1 unchanged or minimally changed | | Pituitary reserve assessment | Normal GH stimulation test | Subnormal peak GH on stimulation | | Cost tolerance | Lower | Higher | | Concurrent anabolic goals | Baseline wellness | Body recomposition, recovery | Dosing the Sermorelin + CJC-1295 Protocol No published RCT has evaluated the combination protocol head-to-head against monotherapy in adults
Take one to two capsules daily
Excessively rapid detoxification symptoms may occur if toxic mobilization outpaces elimination capacity, particularly in individuals with significant heavy metal burdens or compromised detoxification capacity
Vitamin-Related Genetics Do my genes change how I respond to vitamins
Semple EA, Harberson MT, Xu B, Rashleigh R, Cartwright TL, Braun JJ, Custer AC, Liu C, Hill JW